-
2024-512754-16-00
Prostate cancer 5
-
2023-504066-39-00
Prostate Cancer 7
-
2023-509812-27-00
urinary incontinence 9
-
2022-501389-23-00
end-stage renal disease or otherwise an insufficient ki 4
-
2023-505335-12-00
Not applicable. The study will be conducted on healthy 2
-
2023-510191-31-00
Benign Prostate Hyperplasia 5
-
2024-511214-20-00
Complicated forms of idiopathic steroid-sensitive nephr 4
-
2024-520286-31-00
Hot Flush 3
-
2024-519166-48-01
Posterior Urethral Valves 4
-
2025-521551-23-01
prostate cancer 9
-
2025-520978-18-00
Chronic Kidney Disease 1
-
2025-524440-35-00
metastatic castration resistant prostate cancer (mCRPC) 6
-
2025-522145-21-00
Metastatic hormone sensitive prostate cancer 5
-
2023-510355-36-00
Male Urinary Tract Infection 5
-
2023-509812-27-01
urinary incontinence 1
-
2025-523672-23-00
Metastatic Castrate Sensitive Prostate Cancer - mCSPC 4
-
2024-517285-41-00
Newly diagnosed prostate cancer with pelvic lymph nodes 5
-
2025-524703-76-00
Urinary tract infection with systemic involvement (UTI: 5
-
2025-522935-32-00
interstitial cystitis/bladder pain syndrome 3
-
2025-520482-52-03
Prostate cancer 9
-
2025-524774-42-00
Male Infertility 4
-
2024-516446-18-00
Glomerular kidney diseases with proteinuria 1
-
2022-501389-23-02
end-stage renal disease or otherwise an insufficient ki 4
-
2024-514316-27-00
Not muscular invasive bladder cancer 6